Should clindamycin or zosyn (piperacillin/tazobactam) be used in the treatment of necrotizing fasciitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Clindamycin is the preferred choice for the treatment of necrotizing fasciitis caused by group A streptococci, while zosyn (piperacillin/tazobactam) can be used as part of empiric treatment for polymicrobial necrotizing fasciitis.

Key Considerations

  • The treatment of necrotizing fasciitis should include surgical intervention as the primary therapeutic modality, with antimicrobial therapy playing a supportive role 1.
  • For group A streptococcal necrotizing fasciitis, the recommended treatment is penicillin plus clindamycin 1.
  • For polymicrobial necrotizing fasciitis, empiric treatment should include agents effective against both aerobes and anaerobes, such as vancomycin or linezolid plus piperacillin-tazobactam or a carbapenem 1.
  • Clindamycin is useful for coverage of anaerobes and aerobic gram-positive cocci, including most S. aureus serogroups 1.
  • Piperacillin-tazobactam is useful for coverage against resistant gram-negative rods 1.

Treatment Options

  • Clindamycin:
    • Dose: not specified in the guidelines
    • Indication: group A streptococcal necrotizing fasciitis
  • Zosyn (piperacillin/tazobactam):
    • Dose: not specified in the guidelines
    • Indication: polymicrobial necrotizing fasciitis, as part of empiric treatment

Important Notes

  • The choice of antibiotic should be guided by the suspected or confirmed microbial etiology of the infection 1.
  • Antimicrobial therapy should be continued until further debridement is no longer necessary, the patient has improved clinically, and fever has been absent for 48-72 hours 1.

From the Research

Treatment Options for Necrotizing Fasciitis

  • The treatment of necrotizing fasciitis requires a multifaceted approach, consisting of surgical source control with immediate surgical debridement along with life support, clinical monitoring, and antimicrobial therapy 2.
  • Broad-spectrum coverage is advisable, and acceptable monotherapy regimens include piperacillin-tazobactam or a carbapenem 2.
  • Clindamycin can be used in combination with other antibiotics, such as metronidazole, as an alternative to non-betalactam anti-MRSA agents for necrotizing fasciitis management 2.

Antibiotic Prescriptions for Necrotizing Fasciitis

  • The top three empirical antibiotics prescribed for necrotizing fasciitis are ampicillin + sulbactam, clindamycin, and ceftazidime 3.
  • The selection of the antibiotic significantly impacts the outcome of necrotizing fasciitis, and broad-spectrum empirical antibiotics following surgical debridement reduce the mortality rate of NF 3.
  • Clindamycin is recommended as part of the initial calculated antibiotic treatment, in combination with aminopenicillin ± sulbactam and/or metronidazole 4.

Effectiveness of Clindamycin and Piperacillin/Tazobactam

  • Clindamycin has been shown to be effective in treating necrotizing fasciitis, particularly in combination with other antibiotics 4, 5.
  • Piperacillin/tazobactam is a recommended monotherapy regimen for necrotizing fasciitis, providing broad-spectrum coverage 2.
  • The use of clindamycin or piperacillin/tazobactam as part of the treatment regimen for necrotizing fasciitis can improve patient outcomes, including reducing the risk of amputation and mortality 3, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Necrotizing fasciitis: treatment concepts and clinical results.

European journal of trauma and emergency surgery : official publication of the European Trauma Society, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.